HUEXC030

· Orient Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HUEXC030, covering 2022-06-15 to 2022-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Phase 2, Phase 3]